Literature DB >> 17503219

Does evidence-based medicine apply to psychiatry?

Mona Gupta1.   

Abstract

Evidence-based psychiatry (EBP) has arisen through the application of evidence-based medicine (EBM) to psychiatry. However, there may be aspects of psychiatric disorders and treatments that do not conform well to the assumptions of EBM. This paper reviews the ongoing debate about evidence-based psychiatry and investigates the applicability, to psychiatry, of two basic methodological features of EBM: prognostic homogeneity of clinical trial groups and quantification of trial outcomes. This paper argues that EBM may not be the best way to pursue psychiatric knowledge given the particular features of psychiatric disorders and their treatments. As a result, psychiatry may have to develop its own standards for rigour and validity. This paper concludes that EBM has had a powerful influence on how psychiatry investigates and understands mental disorders. Psychiatry could influence EBM in return, reshaping it in ways that are more clinically useful and congruent with patients' needs.

Entities:  

Mesh:

Year:  2007        PMID: 17503219     DOI: 10.1007/s11017-007-9029-x

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  21 in total

Review 1.  The case against "the evidence": a different perspective on evidence-based medicine.

Authors:  D D R Williams; Jane Garner
Journal:  Br J Psychiatry       Date:  2002-01       Impact factor: 9.319

2.  EBM in practice: psychiatry.

Authors:  M A Oakley-Browne
Journal:  Med J Aust       Date:  2001-04-16       Impact factor: 7.738

Review 3.  Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

Authors:  S H Kennedy; R W Lam; N L Cohen; A V Ravindran
Journal:  Can J Psychiatry       Date:  2001-06       Impact factor: 4.356

4.  The randomized controlled trial: gold standard, or merely standard?

Authors:  Jason Grossman; Fiona J Mackenzie
Journal:  Perspect Biol Med       Date:  2005       Impact factor: 1.416

5.  On evidence and evidence-based medicine: lessons from the philosophy of science.

Authors:  Maya J Goldenberg
Journal:  Soc Sci Med       Date:  2005-12-27       Impact factor: 4.634

Review 6.  What are pragmatic trials?

Authors:  M Roland; D J Torgerson
Journal:  BMJ       Date:  1998-01-24

7.  Closing the gap between research and practice.

Authors:  J R Geddes; P J Harrison
Journal:  Br J Psychiatry       Date:  1997-09       Impact factor: 9.319

8.  Utility scores of symptom profiles in major depression.

Authors:  Ayal Schaffer; Anthony J Levitt; Susan K Hershkop; Paul Oh; Cathy MacDonald; Krista Lanctot
Journal:  Psychiatry Res       Date:  2002-06-01       Impact factor: 3.222

Review 9.  Cognitive behaviour therapy for chronic fatigue syndrome in adults.

Authors:  Jonathan R Price; Edward Mitchell; Elizabeth Tidy; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

10.  Evidence-based psychiatry.

Authors:  E M Goldner; D Bilsker
Journal:  Can J Psychiatry       Date:  1995-03       Impact factor: 4.356

View more
  5 in total

1.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 2.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

3.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

4.  Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies.

Authors:  Réka Csehi; Zsófia Borbála Dombi; Barbara Sebe; Mária Judit Molnár
Journal:  Front Psychiatry       Date:  2022-03-17       Impact factor: 4.157

5.  Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists.

Authors:  György Németh; Réka Csehi
Journal:  Front Psychiatry       Date:  2022-09-28       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.